Literature DB >> 27351653

Development of a novel murine model for treatment of infected mesh scenarios.

Arnab Majumder1, Clayton C Petro1, Lijia Liu1, Mojtaba Fayezizadeh1, Yuri W Novitsky2.   

Abstract

BACKGROUND: Indications regarding hernia repair after removal of previously infected prostheses remain unclear. Patients may receive staged primary repair or single-stage reconstructions, neither of which may be ideal. Although animal models have simulated contamination by direct inoculation of implants with bacteria, there remains a paucity of literature, which simulates a field following mesh infection and removal. We aimed to develop a murine model to mimic this complex scenario to allow for further testing of various implants.
METHODS: Thirty-six female CL57BL/6J mice underwent implantation of a 0.7 × 0.7 cm polyester mesh in the dorsal subcutaneous position. Wounds were closed and inoculated with 100 µL containing 1 × 104 CFU of GFP-labeled MSSA. After 2 weeks, the infected mesh was removed and the cavity was copiously irrigated with saline. Mice were split into four groups: with three groups receiving new polyester, polypropylene, and porcine mesh and remaining as non-mesh controls. Mice were survived for another 2 weeks and underwent necropsy. Gross infection was evaluated at 2 and 4 weeks. Tissue homogenization and direct plating to recover GFP MSSA was completed at 4 weeks.
RESULTS: At 2 weeks, all mice were noted to have gross mesh infection. One animal died due to overwhelming infection and wound breakdown. At 4 weeks, 5/6 (83 %) control mice who did not have a second mesh implantation had full clearance of their wounds. In contrast, 9/10 (90 %) mice with re-implantation of polypropylene were noted to have pus and recovery of GFP MSSA on plating. This was also observed in 100 % of mice with polyester and porcine mesh.
CONCLUSION: Our novel murine model demonstrates that mesh re-implantation after infected mesh removal results in infection of the newly placed prosthesis, regardless of the material characteristic or type. This model lays foundation for development and investigation of implants for treatment strategies following infected mesh removal.

Entities:  

Keywords:  Biologic; Contamination; Hernia repair; Infected mesh; Murine model; Synthetic

Mesh:

Year:  2016        PMID: 27351653     DOI: 10.1007/s00464-016-5056-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  17 in total

1.  Multi-staged repair of contaminated primary and recurrent giant incisional herniae in the same hospital admission: a proposal for a new approach.

Authors:  K Siddique; A Shrestha; S Basu
Journal:  Hernia       Date:  2013-02-21       Impact factor: 4.739

2.  Comment to "Long-term outcomes (>5 year follow-up) with porcine acellular dermal matrix (Permacol™) in incisional hernias at risk for infection" by Abdelfatah MM, Rostambeigi N, Podgaetz E, Sarr MG (DOI 10.1007/s10029-013-1165-9).

Authors:  P Negro; L D'Amore; F Ceci; F Gossetti
Journal:  Hernia       Date:  2015-07-14       Impact factor: 4.739

3.  In vivo analysis of the morphologic characteristics of synthetic mesh to resist MRSA adherence.

Authors:  Jeffrey A Blatnik; David M Krpata; Michael R Jacobs; Yue Gao; Yuri W Novitsky; Michael J Rosen
Journal:  J Gastrointest Surg       Date:  2012-08-21       Impact factor: 3.452

4.  Evaluation of wound irrigation by pulsatile jet and conventional methods.

Authors:  L L Brown; H T Shelton; G H Bornside; I Cohn
Journal:  Ann Surg       Date:  1978-02       Impact factor: 12.969

5.  The efficacy of various irrigation solutions in removing slime-producing Staphylococcus.

Authors:  J O Anglen; S Apostoles; G Christensen; B Gainor
Journal:  J Orthop Trauma       Date:  1994-10       Impact factor: 2.512

6.  Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms.

Authors:  Jeff G Leid; Mark E Shirtliff; J W Costerton; Paul Stoodley
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

7.  Outcomes of synthetic mesh in contaminated ventral hernia repairs.

Authors:  Alfredo M Carbonell; Cory N Criss; William S Cobb; Yuri W Novitsky; Michael J Rosen
Journal:  J Am Coll Surg       Date:  2013-09-14       Impact factor: 6.113

8.  A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilizing biologic mesh.

Authors:  Michael J Rosen; David M Krpata; Bridget Ermlich; Jeffrey A Blatnik
Journal:  Ann Surg       Date:  2013-06       Impact factor: 12.969

9.  Does presoaking synthetic mesh in antibiotic solution reduce mesh infections? An experimental study.

Authors:  Emmanuel E Sadava; David M Krpata; Yue Gao; Yuri W Novitsky; Michael J Rosen
Journal:  J Gastrointest Surg       Date:  2012-12-01       Impact factor: 3.452

10.  An experimental comparison of the effects of bacterial colonization on biologic and synthetic meshes.

Authors:  William C Cole; Eric M Balent; Pamela C Masella; Lauren N Kajiura; Karen W Matsumoto; Lisa M Pierce
Journal:  Hernia       Date:  2014-08-01       Impact factor: 4.739

View more
  3 in total

Review 1.  A critical review of the in vitro and in vivo models for the evaluation of anti-infective meshes.

Authors:  O Guillaume; B Pérez Kohler; R Fortelny; H Redl; F Moriarty; R G Richards; D Eglin; A Petter Puchner
Journal:  Hernia       Date:  2018-08-28       Impact factor: 4.739

2.  Effectiveness of Prophylactic Intraperitoneal Mesh Implantation for Prevention of Incisional Hernia in Patients Undergoing Open Abdominal Surgery: A Randomized Clinical Trial.

Authors:  Andreas Kohler; Joel L Lavanchy; Ursina Lenoir; Anita Kurmann; Daniel Candinas; Guido Beldi
Journal:  JAMA Surg       Date:  2019-02-01       Impact factor: 14.766

3.  Prophylactic, Synthetic Intraperitoneal Mesh Versus No Mesh Implantation in Patients with Fascial Dehiscence.

Authors:  Manuel O Jakob; Daniel Spari; Joel Zindel; Tawan Pinworasarn; Daniel Candinas; Guido Beldi
Journal:  J Gastrointest Surg       Date:  2018-07-23       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.